CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Analytics: Where Does it Stand in Life Sciences Industry

Analytics: Where Does it Stand in...

The Plant-Based Market is being Driven by Key Consumer Trends

The Plant-Based Market is being...

Why DNA Sequencing in Biotechnology is Critical

Why DNA Sequencing in Biotechnology...

What You Should Know Aboutthe Human Genome

What You Should Know Aboutthe Human...

Healthcare Packaging Lines: Tips for Improving Sustainability And Performance

Healthcare Packaging Lines: Tips for...

Predictive Analytics: 3 Ways it Can Boost Commercialization Efforts

Predictive Analytics: 3 Ways it Can...

Drug Discovery and Development: Toward a Brighter Future with Big Data

Drug Discovery and Development:...

Data Analytics and Data Science Platforms for Life Sciences

Data Analytics and Data Science...

Analytics: Where Does it Stand in Life Sciences Industry

Analytics: Where Does it Stand in...

The Plant-Based Market is being Driven by Key Consumer Trends

The Plant-Based Market is being...

Why DNA Sequencing in Biotechnology is Critical

Why DNA Sequencing in Biotechnology...

What You Should Know Aboutthe Human Genome

What You Should Know Aboutthe Human...

Healthcare Packaging Lines: Tips for Improving Sustainability And Performance

Healthcare Packaging Lines: Tips for...

Predictive Analytics: 3 Ways it Can Boost Commercialization Efforts

Predictive Analytics: 3 Ways it Can...

Drug Discovery and Development: Toward a Brighter Future with Big Data

Drug Discovery and Development:...

Data Analytics and Data Science Platforms for Life Sciences

Data Analytics and Data Science...

Here's How Data Takes Part in Driving Effective R&D for Life Sciences

Life Sciences Review | Wednesday, January 27, 2021
Tweet

AI-enabled technologies will reduce the time and expense of bringing new treatments on the market, prevent expensive late-stage delays, and simplify regulatory acceptance and monitoring processes.


FREMONT, CA: Healthcare digitization influences the entire value chain and generates vast volumes of heterogeneous data, but it is not adequately relevant or accessible for harnessing. Life sciences and R&D practitioners spend a substantial amount of time analyzing clinical trial notes, medical data sets, and records to identify critical problems (e.g., unintended drug effects) and provide an overall understanding of the content of the document. Such papers and medical notes are incredibly detailed and unstructured, often leading to an accumulation of information and incomplete or lost data. Oncologists require support in developing perspectives and interpreting trends from unstructured records.


Increased R&D Prices and Lead Times


Drug research is now a costly and time-consuming process for mass-market products. However, the need for specialized and tailored healthcare options (including rare diseases) is growing, with the increasing time and expense of regulatory approval making the situation more acute. Drug development and clinical trials usually have two main phases.


See Also: Top Pharma and Life Sciences Analytics Consulting Companies


Usually, phase one may take between three and five years, and phase two may take between six and seven years. It is challenging to shorten this time. There are few financial or human levers available; the amount of analysis work, expertise, and legislation involved means that businesses cannot quickly pour more capital or personnel into the process. The availability of big data resources and data sciences with their power to open the R&D process makes these skills much more important.


AI and Data Science Present a Steady Stream of New Solutions


Artificial Intelligence (AI), computer science, and analytics significantly impact on R&D and drug discovery. These tools and approaches allow researchers to decode associations, behaviors, and genetic factors that drive disease, advance the search and analysis performance of complex chemical spaces. Additionally, they also maximize clinical trials' efficacy by improving the administration, training, patient reporting, and collection of real-world evidence.


AI-enabled technologies will reduce the time and expense of bringing new treatments on the market, prevent expensive late-stage delays, and simplify regulatory acceptance and monitoring processes. They will also offer more customized treatment that has a considerable effect on patients' outcomes and quality of life.


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/here-s-how-data-takes-part-in-driving-effective-rd-for-life-sciences-nwid-231.html